I'm especially interested in Patient 2, rare cancer with metastases in lungs & evidence of partial abscopal response/no new lesions, given lung cancer subjects were the only 2 progressing cases in the CEP trial if I am correct.
Very encouraging leading into RT (palliative) x NOX66 in metastatic prostate patients. Sentiment still "buy"
Ann: Evidence of Abscopal Responses in Patients, page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 52445 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 14492 | 2 |
View Market Depth
| Last trade - 15.02pm 27/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable
